SAFETYCMX-020 has no respiratory depression, addiction, constipation, nausea, dizziness, fatigue, or vertigo
The “Public Health Emergency” associated with the opioid crisis continues to take away people’s lives:
Overdose deaths – 50,000 per year
- More people died in the United States from opioid overdose in 2017 than breast cancer, automobile accidents, and HIV/AIDs at the peak of its epidemic.
Hospital deaths – 20,000 per year
- A JAMA article on May 23, 2018 (Shafi et al, 2018) revealed there may be more than 20,000 deaths in hospital settings in association with the 7.3 million patients surgical and endoscopic procedures conducted with intravenous opioids in the United States every year.
Opioid Addiction – 2 million per year
- 2 million people in the United States suffer from substance use disorders related to prescription opioid pain relievers, and 591,000 suffer from heroin use disorder.
Solution to the opioid crisis: While people are finding ways to minimize the use of opioids, and figuring out better ways to help opioid addicts, the best solution to the opioid epidemic is to eliminate opioids completely, in both hospitals and at home, and replace opioids with a non-narcotic pain reliever that effectively addresses pain without adverse events with both intravenous and oral delivery. This is a role that fits CMX-020 perfectly.